The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has been holding Editorial Board meetings since 2023. The Editorial Board meeting for the Section “Nuclear Medicine & Radiology” was hosted by Section Editor-in-Chief, Prof. Dr. Alberto Signore, and eleven Editorial Board Members were in attendance. We are extremely grateful for the strong support from our Editorial Board Members, and we sincerely hope that more Editorial Board Members will be able to participate in future meetings. We would like to invite everyone to review the content of this meeting.

The meeting started with a presentation about the development of the journal, with a particular focus on the Section “Nuclear Medicine & Radiology”. The following topics were discussed:

• The journal’s history, open access policy, and author benefits;
• Journal publication statistics and analysis of authors’ demographics (2018–2023);
• Journal awards, journal marketing activities, and journal social media promotion;
• Section EBM overview, decision-making statistics, and Section development statistics.

The following topics were covered in the discussion at this Editorial Board meeting:

The meeting mainly revolved around the self-construction and optimization of the Section. It is essential to comprehensively assess its overlapping scope with other journals and formulate a targeted adjustment plan to precisely define the Section's positioning. Promoting monthly highly cited papers and establishing a reward mechanism to attract more high-quality submissions was proposed. In addition, it was recommended to comb through and optimize the distribution of research fields within the Section according to the professional expertise of members, while at the same time actively exploring cutting-edge emerging research directions such as the application of artificial intelligence in radiology into the Section's scope, achieving in-depth expansion and enrichment of content and laying a solid foundation for the section's development.

Simultaneously, the Section should actively strive to expand the team by inviting radiology experts to the Editorial Board. Members should hold regular online meetings (annually) to gather collective wisdom and provide innovative insights and practical strategies for the Section's development. In-depth cooperation and exchanges with relevant international societies should be strengthened to promote the journal's development.

Attendee list (in no particular order):

• Prof. Dr. Alberto Signore (Section Editor-in-Chief), Department of Surgical-Medical Sciences and Translational Medicine, University of Rome Sapienza, Rome, Italy;
• Prof. Dr. Indra J. Das, Department of Radiation Oncology, Northwestern Memorial Hospital, Northwest University Feinberg School of Medicine, Chicago, USA;
• Prof. Dr. Felix M. Mottaghy, ^1. Director, Department of Nuclear Medicine, University Hospital, RWTH University Aachen, Aachen, Germany. ^2. Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), AZ Maastricht, the Netherlands;
• Prof. Dr. Rémy Guillevin, ^1. Department of Imaging, University Hospital Center of Poitiers, Poitiers, France. ². Labcom I3M, University of Poitiers, Poitiers, France;
• Prof. Dr. Olivier Gheysens, Department of Nuclear Medicine, Cliniques Universitaires Saint-Luc and Institute of Clinical and Experimental Research (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium;
• Prof. Dr. Adriaan A. Lammertsma, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;
• Dr. David Ulmert, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA;
• Prof. Dr. Enrico G. Caiani, Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy;
• Prof. Dr. Thomas Vogl, Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;
• Prof. Dr. Martin R. Prince, ^1. Department of Radiology, Weill Cornell Medicine, New York, USA. ^2. Columbia College of Physicians and Surgeons, New York, USA;
• Dr. Carlo Cavaliere, IRCCS Synlab SDN, Naples, Italy;
• Dr. Mario Ganau, Department of Neurosurgery, Oxford University Hospitals NHS Foundation, Oxford, UK.

The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current impact factor of JCM is 3.0 (2023), ranking 59/329 (Q1) in the “Medicine, General & Internal” category.

To access more journal statistics, please click here.

To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Nuclear_Medicine_Radiology.

JCM Editorial Office